They confirmed that the frequency of PD-1+CD8+ T cells has a close relation to that of PD-1+ Treg cells in the tumor microenvironment and this ratio may be a better predictor for PD-1 therapeutic effect. This evidence concerns the gene CD8A and neoplasm.